This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Personal history of allergy to drugs, medicaments and biological substances
Z21_PERSONAL_HISTORY_ALLERGY_DRUGS_MEDICAM_BIOLO_SUBST
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
403 |
4. Check minimum number of eventsNone |
403 |
5. Include endpointsNone |
403 |
6. Filter based on genotype QC (FinnGen only) |
403 |
Control definitions (FinnGen only)
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Z[8-9]
Similar endpoints
↥List of similar endpoints to
Personal history of allergy to drugs, medicaments and biological substances
based on the number of shared cases.
Similar with more cases:
- Persons with potential health hazards related to family and personal history and certain conditions influencing health status
- Factors influencing health status and contact with health services
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 403 | 293 | 110 |
| Unadjusted period prevalence (%) | 0.09 | 0.10 | 0.05 |
| Median age at first event (years) | 53.00 | 51.81 | 56.16 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 350
- Matched controls
- 3499
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Z88.6
ICD-10 Finland
Personal history of allergy to analgesic agent
+∞
211.6
181
*
J33.0
ICD-10 Finland
Polyp of nasal cavity
49.9
94.0
113
33
J32.4
ICD-10 Finland
Chronic pansinusitis
74.2
90.4
101
19
XQ800
NOMESCO Finland
Prick test
17.4
88.1
151
146
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
44.3
84.3
104
33
C01CA24
ATC
epinephrine; parenteral
17.7
78.5
131
114
UDH02
NOMESCO Finland
Rhinopharyngoscopy
17.8
75.9
126
107
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
20.1
73.9
116
84
J45.1
ICD-10 Finland
Nonallergic asthma
16.8
73.5
125
112
J33.8
ICD-10 Finland
Other polyp of sinus
42.8
72.6
90
28
R03DC03
ATC
montelukast; oral
9.1
68.5
175
345
J45.0
ICD-10 Finland
Predominantly allergic asthma
12.4
68.3
136
170
DHB20
NOMESCO Finland
Polypectomy of internal nose
74.2
67.9
76
13
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
8.6
67.1
182
392
R01AD08
ATC
fluticasone; nasal
6.9
60.5
218
678
Z88.8
ICD-10 Finland
Personal history of allergy to other drugs, medicaments and biological substances
+∞
59.1
55
*
J45.9
ICD-10 Finland
Asthma, unspecified
7.8
58.1
163
352
H02AB06
ATC
prednisolone; systemic
6.1
52.8
254
1061
TDM10
NOMESCO Finland
Puncture of maxillary antrum
17.8
52.6
85
62
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
11.2
50.2
102
124
Z88.1
ICD-10 Finland
Personal history of allergy to other antibiotic agents
+∞
46.9
44
*
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
15.4
45.2
77
63
R03AC02
ATC
salbutamol; inhalant
5.3
42.1
274
1418
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
17.1
40.2
65
46
H02AB07
ATC
prednisone; oral
6.4
38.4
116
252
DPA30
NOMESCO Finland
Sphenotomy
51.4
37.9
45
10
R01AD05
ATC
budesonide; nasal
7.9
36.4
90
146
ZXA10
NOMESCO Finland
Bilateral
5.4
35.2
125
326
R03BB04
ATC
tiotropium bromide; inhalant
8.2
35.0
84
130
R03AK06
ATC
salmeterol and fluticasone; inhalant
5.8
34.5
113
267
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
6.2
31.7
95
199
R06AE07
ATC
cetirizine; oral
3.9
31.7
231
1165
R03BA02
ATC
budesonide; inhalant
4.7
31.2
127
376
H02AB04
ATC
methylprednisolone; systemic
5.3
30.4
106
265
R03BA05
ATC
fluticasone; inhalant
4.6
30.0
127
389
ZXE00
NOMESCO Finland
One hour or less
3.7
29.0
200
932
DPA25
NOMESCO Finland
Trephine of frontal sinus through nose
51.8
28.0
33
7
Z3231
NOMESCO Finland
Registered nurse
3.9
27.8
146
539
ZXE10
NOMESCO Finland
More than one and less than three hours
3.6
27.1
180
800
J46
ICD-10 Finland
Status asthmaticus
14.5
27.0
46
36
J33.9
ICD-10 Finland
Nasal polyp, unspecified
50.1
27.0
32
7
Z2221
NOMESCO Finland
Medical doctor
3.7
26.4
158
643
ZXD10
NOMESCO Finland
Scheduled procedure
3.4
26.1
190
898
J45
ICD-10 Finland
Asthma
5.6
24.7
78
170
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
5.7
24.6
77
166
T78.4
ICD-10 Finland
Allergy, unspecified
8.3
24.5
56
78
N02AX02
ATC
tramadol; systemic, rectal
3.3
24.1
186
903
R03DA04
ATC
theophylline; systemic, rectal
10.0
24.0
49
56
R03AC13
ATC
formoterol; inhalant
9.0
23.5
51
65
Z88.9
ICD-10 Finland
Personal history of allergy to unspecified drugs, medicaments and biological substances
+∞
23.2
22
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.5
23.0
139
557
WX002
NOMESCO Finland
Sedation and analgesia
4.1
22.8
103
324
R03AC12
ATC
salmeterol; inhalant
9.4
22.3
47
57
R06AX27
ATC
desloratadine; oral
3.2
21.8
156
703
R03AK07
ATC
formoterol and budesonide; inhalant
3.6
21.5
120
447
Z88.0
ICD-10 Finland
Personal history of allergy to penicillin
222.7
20.8
21
*
R01AD09
ATC
mometasone; nasal
3.0
20.8
218
1253
XQ820
NOMESCO Finland
Exposure to medicinal substance
111.4
19.8
21
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.9
19.7
169
842
R06AX13
ATC
loratadine; oral
3.6
19.2
101
354
R03AC03
ATC
terbutaline; inhalant
3.9
19.1
90
288
R03AK08
ATC
formoterol and beclometasone; inhalant
8.8
18.9
41
52
R01AD12
ATC
fluticasone furoate; nasal
2.9
18.8
161
794
J01FA06
ATC
roxithromycin; oral
2.8
18.7
180
957
R4110
NOMESCO Finland
Physiotherapy
3.1
18.1
127
548
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
7.8
18.0
42
60
R06AE09
ATC
levocetirizine; oral
3.5
17.9
96
341
J01FF01
ATC
clindamycin; systemic
3.1
17.8
122
516
J01AA02
ATC
doxycycline; systemic
3.4
17.7
297
2190
ZXC95
NOMESCO Finland
Use of surgical navigator
18.2
17.7
27
16
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
7.1
17.2
43
68
4222
FHL
Endonasal etmoidectomy
66.7
16.9
19
*
Z88.4
ICD-10 Finland
Personal history of allergy to anaesthetic agent
+∞
16.8
16
*
Z3226
NOMESCO Finland
Physiotherapist
3.3
16.4
94
348
Z01.8
ICD-10 Finland
Other specified special examinations
3.1
16.1
103
412
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
11.2
16.0
30
29
ZXD20
NOMESCO Finland
Day surgery
3.8
15.8
73
227
WX402
NOMESCO Finland
General anaesthesia
3.3
15.8
91
337
J01FA09
ATC
clarithromycin; systemic
2.7
15.5
150
771
GX1L5
NOMESCO Finland
Exhaled nitric oxide analysis
47.2
15.2
18
*
M01AE01
ATC
ibuprofen; systemic, rectal
0.4
14.9
222
2890
J45.8
ICD-10 Finland
Mixed asthma
7.7
14.7
34
48
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.9
14.6
101
423
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
12.1
14.5
26
23
J01FA10
ATC
azithromycin; systemic
2.5
14.5
248
1716
DHA10
NOMESCO Finland
Biopsy of cavity of nose
25.0
13.9
19
8
Z96.1
ICD-10 Finland
Presence of intraocular lens
14.4
13.9
23
17
D72.1
ICD-10 Finland
Eosinophilia
55.7
13.9
16
*
N02BE01
ATC
paracetamol; systemic, rectal
3.3
13.7
311
2484
4711A
ICD-9 Finland
Nasal polyps, Polypoid sinus degeneration
78.3
13.7
15
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
5.3
13.7
42
87
J01MA14
ATC
moxifloxacin; systemic
4.2
13.6
53
141
R03BA08
ATC
ciclesonide; inhalant
4.2
13.5
54
147
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
15.9
13.3
21
14
J33
ICD-10 Finland
Nasal polyp
41.8
13.3
16
*
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.4
13.2
183
1112
R03BA01
ATC
beclometasone; inhalant
3.2
13.1
75
272
DHB50
NOMESCO Finland
Turbinoplasty
7.8
12.8
29
40
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
2.5
12.6
116
570
R01BA52
ATC
pseudoephedrine, combinations; oral
2.4
12.5
139
750
J32.2
ICD-10 Finland
Chronic ethmoidal sinusitis
16.7
12.3
19
12
TPH04
NOMESCO Finland
Cathetrisation of vein
2.9
12.1
83
341
ZXA05
NOMESCO Finland
Left side
2.7
11.9
95
427
R06.0
ICD-10 Finland
Dyspnoea
2.6
11.8
99
458
R02
ICPC
Shortness of breath/dyspnoea
3.6
11.8
55
171
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
2.2
11.6
187
1195
R96
ICPC
Asthma
3.9
11.6
49
140
R03AK11
ATC
formoterol and fluticasone; inhalant
7.7
11.5
26
36
DMB00
NOMESCO Finland
Endonasal trephine of maxillary antrum
36.3
11.3
14
*
T78.2
ICD-10 Finland
Anaphylactic shock, unspecified
13.3
11.3
19
15
R03DC01
ATC
zafirlukast; oral
11.7
11.2
20
18
Z51.6
ICD-10 Finland
Desensitization to allergens
12.5
11.0
19
16
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.4
10.8
111
567
N02AJ06
ATC
codeine and paracetamol; systemic
2.2
10.6
148
877
R01AD01
ATC
beclometasone; nasal
2.7
10.5
77
327
S01GX01
ATC
cromoglicic acid; ophthalmic
2.5
10.5
96
462
J33.1
ICD-10 Finland
Polypoid sinus degeneration
+∞
10.5
10
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.7
10.4
78
333
J32.8
ICD-10 Finland
Other chronic sinusitis
24.2
10.3
14
6
A02BC02
ATC
pantoprazole; systemic
2.1
10.2
232
1680
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.9
10.2
65
253
ZX112
NOMESCO Finland
Subcutaneous
9.6
10.2
20
22
R06AX22
ATC
ebastine; oral
2.5
10.1
92
441
J01MA02
ATC
ciprofloxacin; systemic
2.2
10.1
139
813
T88.6
ICD-10 Finland
Anaphylactic shock due to adverse effect of correct drug or medicament properly administered
41.3
10.0
12
*
R03BB01
ATC
ipratropium bromide; inhalant
7.0
9.6
23
35
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
15.6
9.6
15
10
H65.3
ICD-10 Finland
Chronic mucoid otitis media
6.5
9.6
24
39
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.0
9.5
204
1422
XQ801
NOMESCO Finland
Intracutantest
102.7
9.5
10
*
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
+∞
9.4
9
*
XG474
NOMESCO Finland
Exhalation nntrogen oxide
6.0
9.4
25
44
ZXD05
NOMESCO Finland
Urgent procedure
2.2
9.3
118
659
Z01.7
ICD-10 Finland
Laboratory examination
3.0
9.3
56
209
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
5.2
9.0
27
55
DFF00
NOMESCO Finland
Pure tone audiometry
3.8
9.0
38
109
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
8.3
9.0
19
24
X59
ICD-10 Finland
Exposure to unspecified factor
2.5
9.0
80
377
A02BC05
ATC
esomeprazole; systemic
2.1
9.0
146
905
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
5.0
9.0
28
60
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
5.6
8.9
25
47
J01MA12
ATC
levofloxacin; systemic
2.6
8.8
69
301
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.9
8.7
55
213
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
4.1
8.6
33
87
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
16.8
8.6
13
8
J01.9
ICD-10 Finland
Acute sinusitis, unspecified
5.3
8.5
25
50
J34.2
ICD-10 Finland
Deviated nasal septum
4.3
8.5
31
78
DJD20
NOMESCO Finland
Plastic repair of septum of nose
5.5
8.5
24
46
L50.9
ICD-10 Finland
Urticaria, unspecified
5.0
8.4
26
55
R50.9
ICD-10 Finland
Fever, unspecified
2.7
8.4
59
243
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.0
8.4
142
888
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
+∞
8.4
8
*
J01DA06
ATC
[U] cefuroxime; systemic
2.5
8.4
67
298
Z3229
NOMESCO Finland
Other healthcare associate professional
3.9
8.3
34
95
XF400
NOMESCO Finland
ECG with 12 standard connections
2.7
8.2
60
250
J01DB01
ATC
cefalexin; oral
2.3
8.2
295
2456
E0000UV
ATC
NA
2.0
7.9
151
980
J01DC02
ATC
cefuroxime; systemic
3.6
7.9
35
105
4730A
ICD-9 Finland
Chronic sinusitis, Maxillary
11.2
7.9
14
13
WX110
NOMESCO Finland
Local anesthesy
2.0
7.8
255
2013
R53
ICD-10 Finland
Malaise and fatigue
2.3
7.8
80
403
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.0
7.7
112
656
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.6
7.7
55
230
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.6
7.6
58
251
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
10.4
7.6
14
14
C03CA01
ATC
furosemide; systemic
2.4
7.5
67
315
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.4
7.5
67
316
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.7
7.5
50
200
297
Kela drug reimbursment
NA
81.8
7.4
8
*
3028
Kela drug reimbursment
Mepolizumab
81.8
7.4
8
*
R03DX09
ATC
mepolizumab; parenteral
81.8
7.4
8
*
Z2446
NOMESCO Finland
Social worker
3.5
7.4
33
100
J02AC02
ATC
itraconazole; systemic
2.2
7.4
77
390
XF404
NOMESCO Finland
Ambulatory ECG
3.2
7.4
37
123
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
3.4
7.3
35
112
L50.0
ICD-10 Finland
Allergic urticaria
6.0
7.3
19
33
DNB10
NOMESCO Finland
Endonasal ethmoidectomy
+∞
7.3
7
*
Z88.2
ICD-10 Finland
Personal history of allergy to sulfonamides
+∞
7.3
7
*
D07AC01
ATC
betamethasone; topical
2.0
7.2
120
737
4931A
ICD-9 Finland
Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]
20.5
7.2
10
5
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
4.9
7.2
22
47
ZXA00
NOMESCO Finland
Right side
2.1
7.0
91
504
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.9
7.0
42
158
M79.6
ICD-10 Finland
Pain in limb
1.9
7.0
128
812
J02AC01
ATC
fluconazole; systemic
1.8
6.9
165
1144
X49
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances
14.1
6.9
11
8
4939X
ICD-9 Finland
Asthma, unspecified[ASTHMA BRONCHIALE NUD]
14.1
6.9
11
8
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.2
6.8
71
357
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
2.8
6.8
44
173
D07AB08
ATC
desonide; topical
2.7
6.8
47
192
4700A
ICD-9 Finland
Deflected nasal septum[DEFORMATIO SEPTI NASI]
17.1
6.8
10
6
H04.10
ICD-10 Finland
Dry eye syndrome
2.8
6.8
43
167
UDM02
NOMESCO Finland
Sinoscopy
6.7
6.7
16
25
E66.8
ICD-10 Finland
Other obesity
3.5
6.6
29
87
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
9.0
6.6
13
15
N03AX16
ATC
pregabalin; oral
2.1
6.6
79
423
Z71.8
ICD-10 Finland
Other specified counselling
2.0
6.6
93
534
J30.3
ICD-10 Finland
Other allergic rhinitis
4.1
6.5
24
62
R06AX26
ATC
fexofenadine; oral
3.0
6.4
36
127
DPA20
NOMESCO Finland
Trephine of frontal sinus
71.1
6.4
7
*
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.9
6.4
109
670
T78.3
ICD-10 Finland
Angioneurotic oedema
8.4
6.4
13
16
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.9
6.4
37
136
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.2
6.3
32
108
4221
FHL
Polyp removal from the nasal cavity, sinus puncture or irrigation, or biopsy under general anesthesia or operating room
18.4
6.3
9
5
T78.1
ICD-10 Finland
Other adverse food reactions, not elsewhere classified
+∞
6.3
6
*
Z88.7
ICD-10 Finland
Personal history of allergy to serum and vaccine
+∞
6.3
6
*
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.0
6.3
94
549
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
6.2
96
569
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.2
6.2
67
340
XF600
NOMESCO Finland
Bloodpressure measurement
3.3
6.2
29
92
4224
FHL
Endonasal anthrostomy
10.3
6.1
11
11
49300
ICD-8 Finland
Asthma, bronchiale
6.2
6.1
15
25
J01DA08
ATC
[U] cefaclor; oral
2.3
6.0
57
273
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3005322) IgE [Units/volume] in Serum or Plasma
164
231
11.29
120.35
2.0
1.2
u/ml
227.7
283.6
0.22
157
217
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
80
77
12.72
75.18
1.5
1.1
u/ml
0.5
2.8
0.85
66
29
(3003888) Timothy IgE Ab [Units/volume] in Serum
76
70
13.15
73.42
1.4
1.1
u/ml
1.7
6.1
1.40
65
37
(3010726) Horse dander IgE Ab [Units/volume] in Serum
72
62
13.92
72.50
1.4
1.0
u/ml
0.5
3.1
0.86
42
12
(42870588) Differential panel, method unspecified - Blood
273
1014
6.25
70.91
7.1
5.5
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
73
68
12.89
69.90
1.5
1.1
u/ml
0.3
0.7
0.76
61
30
(4010399)
117
216
7.22
64.76
1.8
1.4
—
—
—
0
0
(3000492) Spirometry study
139
330
5.90
58.89
1.7
1.3
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
323
1613
6.05
53.00
8.2
5.6
e9/l
0.6
0.6
0.89
274
1424
(3022096) Basophils/100 leukocytes in Blood
306
1465
5.52
52.88
8.4
5.6
%
0.8
0.7
2.14
297
1373
(3006315) Basophils [#/volume] in Blood
323
1621
6.00
52.44
8.2
5.7
e9/l
0.0
0.0
4.62
274
1431
(3007853) Bacteria identified in Skin by Aerobe culture
135
343
5.41
52.36
2.4
1.4
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
309
1513
5.47
51.25
8.4
5.6
%
4.4
2.7
13.06
299
1421
(3013115) Eosinophils [#/volume] in Blood
327
1679
6.02
50.98
8.5
6.2
e9/l
0.3
0.2
14.84
283
1509
(3019069) Monocytes/100 leukocytes in Blood
308
1525
5.33
49.77
8.6
5.8
%
8.0
8.3
1.53
299
1440
(3019198) Lymphocytes [#/volume] in Blood
323
1672
5.69
48.97
8.4
5.7
e9/l
2.0
2.0
0.09
281
1509
(3021589) Normoblasts [#/volume] in Blood
296
1438
4.99
48.57
10.1
8.0
e9/l
0.0
0.0
0.82
223
1195
(40758558) Short blood count panel - Blood
209
789
4.43
48.40
7.1
6.3
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
41
28
16.19
46.58
1.3
1.0
u/ml
1.1
0.1
—
21
10
(3018010) Neutrophils/100 leukocytes in Blood
307
1563
5.05
46.54
8.4
5.4
%
55.6
56.5
0.78
298
1481
(3002030) Lymphocytes/100 leukocytes in Blood
308
1578
5.04
46.14
8.6
5.6
%
28.3
29.4
1.21
299
1489
(3013650) Neutrophils [#/volume] in Blood by Automated count
339
1885
6.03
45.31
11.2
8.9
e9/l
4.1
4.0
0.31
291
1662
(3023430) Cat dander IgE Ab [Units/volume] in Serum
46
48
10.69
40.23
1.4
1.0
u/ml
2.3
4.6
0.43
39
15
(3014133) Dog dander IgE Ab [Units/volume] in Serum
47
55
9.54
37.75
1.4
1.0
u/ml
1.4
3.8
0.43
40
18
(3042936) Bacteria identified in Isolate by Culture
124
375
4.33
37.44
2.8
1.9
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
41
47
9.60
33.36
1.4
1.0
u/ml
0.0
0.8
—
34
9
(3033658) Prothrombin time (PT) actual/Normal
164
751
3.00
24.46
4.7
3.2
%
93.0
96.3
0.81
159
729
(3030467) Casts [#/volume] in Urine by Automated count
166
791
2.87
22.68
4.0
2.6
e6/l
0.2
0.4
1.40
117
594
(3000494) Fungus identified in Specimen by Culture
102
382
3.24
21.23
2.2
1.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
162
792
2.75
20.70
4.1
2.6
—
—
—
0
0
(4062490)
26
31
8.90
20.35
1.8
1.1
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
26
31
8.90
20.35
1.6
1.1
g/l
0.3
0.4
0.41
21
24
(3028192) IgG subclass 2 [Mass/volume] in Serum
26
31
8.90
20.35
1.6
1.1
g/l
2.9
3.0
0.08
21
24
(3027135) IgG subclass 1 [Mass/volume] in Serum
26
31
8.90
20.35
1.6
1.1
g/l
6.0
6.4
0.29
21
24
(3002582) Erythrocytes [#/volume] in Urine
168
861
2.63
19.25
4.2
2.7
e6/l
15.5
75.2
2.37
123
663
(3023368) Bacteria identified in Blood by Culture
136
635
2.72
18.71
5.6
3.8
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
24
29
8.74
18.57
2.5
2.2
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
31
51
6.50
18.39
2.0
1.7
g/l
1.0
0.9
0.23
25
44
(3018095) Leukocytes [#/volume] in Urine
190
1057
2.51
18.04
4.8
3.1
e6/l
16.2
61.8
3.53
131
727
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
79
279
3.28
17.91
2.9
1.9
u/l
26.9
32.7
0.82
66
235
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
100
420
2.84
16.65
3.2
2.6
e6/l
4.7
3.0
0.53
43
226
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
76
279
3.12
16.06
2.0
1.6
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
105
464
2.71
15.77
3.0
2.4
e6/l
0.9
1.0
0.28
47
265
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
76
285
3.05
15.45
2.0
1.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
216
1340
2.32
15.28
2.4
1.9
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
107
488
2.62
15.02
5.1
2.8
ng/l
1375.2
375.1
0.37
72
325
(3018418) pH of Serum or Plasma
155
841
2.37
14.92
3.9
3.3
ph
7.4
7.4
0.78
27
139
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
237
1542
2.30
14.80
6.5
5.6
umol/l
10.9
11.0
0.04
225
1464
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
177
1022
2.31
14.69
4.2
2.7
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
121
605
2.43
13.85
3.5
2.2
e6/l
6.3
6.0
0.11
103
526
(3044889) 12 lead EKG panel
294
2144
2.37
13.35
4.1
3.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
61
225
3.02
12.66
1.2
1.2
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
165
973
2.18
12.54
3.4
2.9
mmol/l
2.4
2.4
0.28
149
863
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
88
400
2.54
12.22
2.1
1.7
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
190
1194
2.12
12.16
5.0
4.0
g/l
36.3
36.5
0.18
175
1111
(3000991) Gas panel - Venous blood
53
192
3.03
11.32
9.7
8.2
—
—
—
0
0
(1002224) Polysomnography panel
48
167
3.13
10.98
1.1
1.1
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
41
130
3.40
10.89
7.7
7.5
mmol/l
25.4
25.0
0.36
41
130
(3007164) IgA [Mass/volume] in Serum or Plasma
129
724
2.15
10.84
1.8
1.4
g/l
2.2
2.3
0.34
82
457
(3009542) Hematocrit [Volume Fraction] of Blood
379
3243
3.83
10.54
24.1
11.5
%
40.4
40.2
0.23
321
2565
(40768443) Skin Pathology biopsy report
40
128
3.36
10.47
1.3
1.2
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
60
245
2.70
10.26
3.2
2.0
g/l
10.5
10.2
0.25
55
224
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
74
335
2.48
10.26
3.2
2.4
umol/l
5.0
7.6
1.10
63
289
(3018677) aPTT in Platelet poor plasma by Coagulation assay
83
396
2.38
10.26
1.9
1.9
s
29.7
29.5
0.07
83
386
(3013707) Erythrocyte sedimentation rate by Westergren method
309
2417
2.19
10.14
5.6
3.7
mm/h
11.4
10.3
0.83
295
2246
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
386
3366
4.48
9.91
21.7
10.5
mg/l
24.1
20.6
1.09
331
2559
(3036481) Cortisol [Moles/volume] in Serum or Plasma
67
296
2.52
9.76
2.6
2.1
nmol/l
304.3
372.9
2.38
62
272
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
95
495
2.20
9.48
3.0
2.7
mmol/l
2.4
2.4
0.12
79
431
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
15
23
6.74
9.41
1.5
1.2
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
166
1067
1.95
9.32
4.1
3.1
u/l
26.1
29.3
1.71
160
1019
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
57
241
2.59
9.07
4.5
3.0
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
184
1235
1.90
8.98
6.7
5.1
mmol/l
1.2
1.2
2.14
175
1132
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
198
1362
1.89
8.95
7.5
5.7
mmol/l
1.2
1.2
1.00
170
1168
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
121
706
2.02
8.91
2.1
1.7
mg/l
1.4
1.0
0.22
96
544
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
296
2330
2.02
8.80
3.3
2.8
u/l
38.5
42.1
0.58
287
2213
(3026782) Osmolality of Urine
101
554
2.10
8.78
3.7
2.2
mosm/kgh2o
542.9
572.3
0.52
85
470
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
12
16
7.70
8.45
1.9
2.7
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
301
2404
2.00
8.30
9.4
6.6
u/l
74.3
77.2
0.79
289
2243
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
16
30
5.51
8.27
6.1
2.9
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
11
5
22.55
8.05
1.3
1.0
%
93.8
104.2
—
11
5
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
11
5
22.55
8.05
1.3
1.0
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
11
14
8.05
8.02
2.2
2.4
u/ml
657.4
533.1
0.18
11
14
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
22
56
4.10
7.99
1.7
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
22
56
4.10
7.99
1.7
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
130
818
1.87
7.47
1.8
1.6
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
14
26
5.54
7.30
1.1
1.1
u/ml
0.1
0.1
—
7
8
(3003327) Ova and parasites identified in Stool by Light microscopy
35
129
2.88
7.23
2.0
1.6
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
143
937
1.82
7.16
3.2
2.3
u/l
50.2
56.3
1.73
134
878
(3030905) Polymorphonuclear cells [#/volume] in Blood
22
61
3.76
7.12
3.0
3.7
e9/l
4.8
4.3
0.39
22
61
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
36
136
2.81
7.11
1.6
1.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
22
62
3.70
6.97
3.0
4.2
%
59.6
57.1
0.48
22
62
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
23
67
3.58
6.95
1.3
1.5
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
69
361
2.10
6.68
2.2
2.0
g/l
2.4
2.4
0.00
61
332
(3011412) CD3 cells [#/volume] in Blood
12
21
5.86
6.62
1.5
2.5
e9/l
1.7
1.5
—
5
11
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
158
1088
1.74
6.56
2.0
1.8
pmol/l
94.7
97.5
0.28
85
581
(3027315) Oxygen [Partial pressure] in Blood
16
37
4.46
6.55
6.2
2.8
kpa
8.7
8.8
0.17
16
37
(3013290) Carbon dioxide [Partial pressure] in Blood
16
37
4.46
6.55
6.3
2.8
kpa
5.2
5.0
0.45
16
37
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
356
3114
2.23
6.41
18.1
9.6
ml/min/173m2
87.5
88.0
0.18
314
2519
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
6
0
+∞
6.26
1.2
0.0
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
117
749
1.79
6.19
3.0
2.2
umol/l
11495.4
5811.1
0.29
99
655
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
27
94
3.01
6.17
2.0
1.5
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
27
94
3.01
6.17
2.0
1.5
g/l
4.0
3.9
0.10
22
74
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
27
94
3.01
6.17
2.0
1.5
g/l
7.5
7.6
0.14
22
77
(3003396) Base excess in Arterial blood by calculation
53
260
2.20
6.03
9.2
8.1
mmol/l
1.8
1.4
0.27
41
206
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
180
1311
1.67
5.93
2.4
2.2
nmol/l
72.2
76.5
1.33
161
1198
(3032080) INR in Blood by Coagulation assay
146
1007
1.71
5.90
9.4
5.6
inr
1.1
1.1
0.01
47
314
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
32
126
2.67
5.86
2.3
1.6
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
34
140
2.56
5.71
1.6
1.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
113
732
1.76
5.68
2.8
3.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
42
192
2.33
5.64
1.3
1.2
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
71
399
1.95
5.61
2.3
2.0
umol/l
13.1
14.1
0.55
66
370
(44813793)
12
25
4.92
5.53
1.2
1.1
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
62
336
2.00
5.43
2.4
2.1
%
19.9
23.9
1.79
53
296
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
30
119
2.64
5.43
10.0
9.0
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
269
2211
1.65
5.23
6.1
3.7
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
23
81
2.95
5.17
3.1
3.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
15
40
3.86
5.13
5.4
2.2
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
8
6
13.57
5.10
1.0
1.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
79
475
1.82
5.06
1.6
1.3
titre
326.7
590.9
1.28
18
101
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
307
2625
1.71
4.99
4.8
4.0
pmol/l
14.3
14.5
0.66
287
2423
(3013826) Glucose [Moles/volume] in Serum or Plasma
219
1724
1.59
4.98
6.7
4.0
mmol/l
6.4
6.5
0.29
206
1585
(3012544) pH of Venous blood
46
231
2.12
4.94
3.8
3.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
27
107
2.63
4.90
1.1
1.2
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
33
145
2.39
4.85
12.1
9.9
%
93.0
94.0
0.25
33
145
(3026008) Bacteria identified in Urine by Culture
128
890
1.64
4.85
3.0
2.4
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
48
248
2.06
4.79
2.1
2.3
g/l
0.2
0.2
0.32
43
234
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
295
2509
1.66
4.75
4.3
3.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
15
43
3.58
4.66
2.5
1.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
133
945
1.61
4.58
2.5
2.0
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
44
224
2.08
4.56
3.8
3.2
mmol/l
1.5
2.2
0.61
39
166
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
102
681
1.67
4.48
2.3
1.9
mg/l
2.9
2.9
0.04
90
586
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
26
106
2.55
4.48
1.1
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
16
50
3.29
4.38
1.7
2.7
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
43
221
2.06
4.35
1.3
1.3
iu/l
18.6
25.3
0.99
35
188
(46235355) HIV 1 and 2 tests - Meaningful Use set
114
793
1.61
4.24
2.0
1.9
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
47
253
1.97
4.20
3.8
2.7
%
1.9
1.7
0.33
42
235
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
38
189
2.12
4.19
1.4
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
26
110
2.46
4.16
1.1
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
24
98
2.54
4.13
1.3
1.3
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
196
1548
1.52
4.11
3.6
2.6
ug/l
139.9
84.7
0.70
181
1444
(3021960) Folate [Moles/volume] in Serum or Plasma
91
605
1.65
4.03
1.6
1.4
nmol/l
18.4
21.1
1.42
79
515
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
383
3570
2.47
4.00
13.3
8.9
u/l
25.6
26.0
0.20
377
3459
(3021879) Hepatitis B virus core Ab [Presence] in Serum
48
266
1.91
3.95
1.4
1.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
16
54
3.04
3.89
2.4
2.5
u/ml
0.3
0.3
—
10
26
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
16
54
3.04
3.89
2.1
1.4
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
47
260
1.91
3.88
4.8
4.7
u/l
224.1
234.2
0.46
47
251
(40760892) CBC W Ordered Manual Differential panel - Blood
115
817
1.57
3.87
5.8
4.6
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
382
3563
2.38
3.87
16.2
9.9
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
344
3104
1.74
3.80
5.8
4.6
mu/l
1.7
2.2
0.67
329
2877
(3023103) Potassium [Moles/volume] in Serum or Plasma
365
3352
1.94
3.80
22.7
11.3
mmol/l
3.9
3.9
3.49
359
3252
(40767503) Oxygen content in Capillary blood by calculation
13
39
3.41
3.79
2.7
2.3
%
17.7
16.3
—
5
22
(3035350) Ketones [Presence] in Urine by Test strip
198
1589
1.48
3.72
3.9
3.2
estimate
0.0
0.0
0.00
36
308
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
10
25
4.08
3.72
1.9
2.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
200
1610
1.48
3.69
5.9
4.3
estimate
0.0
0.0
0.50
37
314
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
8
12
6.77
3.69
2.8
4.5
nmol/l
173.6
106.9
—
8
12
(3014599) Egg white IgE Ab [Units/volume] in Serum
11
30
3.74
3.66
1.2
1.1
u/ml
0.4
0.5
—
5
9
(3019230) Fractional oxyhemoglobin in Venous blood
13
40
3.33
3.65
1.8
2.7
%
53.7
60.8
0.53
13
40
(3009261) Glucose [Presence] in Urine by Test strip
201
1626
1.47
3.59
3.9
3.2
estimate
0.0
0.0
0.50
36
305
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
26
119
2.27
3.53
2.1
1.6
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
48
277
1.83
3.50
1.2
1.2
iu/ml
157.9
163.3
0.03
12
114
(3020630) Protein [Mass/volume] in Serum or Plasma
38
203
1.96
3.48
2.0
2.2
g/l
66.9
67.8
0.30
32
188
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
38
203
1.96
3.48
3.1
3.0
ng/l
84.4
65.1
0.93
32
183
(3000570) Elastase.pancreatic [Mass/mass] in Stool
21
89
2.43
3.38
1.4
1.2
ug/g
312.3
334.0
—
10
50
(3027231) Wheat IgE Ab [Units/volume] in Serum
7
10
7.10
3.37
1.3
1.0
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
49
288
1.80
3.37
1.2
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
23
102
2.33
3.36
1.2
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
66
424
1.67
3.32
1.2
1.2
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
47
274
1.81
3.32
23.4
13.6
inr
1.1
1.2
—
5
43
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
99
705
1.54
3.24
2.4
2.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
182
1466
1.44
3.21
4.2
3.7
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
13
44
3.02
3.16
1.0
1.0
g/l
1.3
1.4
0.91
13
38
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
37
203
1.91
3.15
3.9
3.3
pmol/l
4.1
4.6
3.56
32
181
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
15
56
2.74
3.09
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
11
34
3.30
3.08
1.1
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
11
34
3.30
3.08
1.1
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
11
34
3.30
3.08
1.1
1.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
8
16
5.08
3.06
1.4
1.0
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
73
491
1.59
3.06
1.8
2.3
ug/g
89.8
117.2
0.40
63
388
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
13
45
2.95
3.05
1.4
1.4
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
9
21
4.36
3.01
2.8
2.1
%
92.6
90.4
—
9
21
(3004588) Protein electrophoresis panel - Serum or Plasma
31
163
1.98
2.99
2.1
2.0
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
113
842
1.48
2.96
1.4
1.3
u/ml
0.6
1.7
1.31
25
236
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
133
1024
1.45
2.94
4.0
2.8
ng/l
17.1
30.1
1.50
75
592
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
22
102
2.22
2.92
1.2
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
28
144
2.01
2.88
3.1
5.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
70
473
1.58
2.88
1.6
1.4
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
17
71
2.46
2.84
1.6
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
345
3174
1.60
2.83
4.2
3.9
mmol/l
5.8
5.8
0.08
320
2931
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
16
65
2.52
2.82
1.2
1.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
7
14
5.07
2.74
1.1
2.1
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
7
14
5.07
2.74
1.1
2.1
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
31
169
1.90
2.71
1.4
1.6
mu/l
404.4
295.5
0.42
24
154
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
6
10
6.07
2.70
1.3
3.5
%
199.0
105.3
—
6
10
(3000093) Morphology [Interpretation] in Blood Narrative
9
24
3.81
2.68
1.0
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
14
55
2.60
2.64
1.2
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
7
15
4.73
2.60
3.7
3.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
11
38
2.95
2.60
1.8
2.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
16
68
2.41
2.59
1.3
1.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
13
50
2.65
2.55
1.2
4.3
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
5
7
7.21
2.55
4.8
5.4
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
10
33
3.08
2.54
1.1
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
10
33
3.08
2.54
1.1
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
10
33
3.08
2.54
1.1
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
18
82
2.25
2.51
1.3
1.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
65
447
1.54
2.48
1.7
1.6
nmol/l
1132.3
1202.4
0.23
47
340
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
37
221
1.74
2.44
1.1
1.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
10
34
2.99
2.43
1.0
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
21
104
2.08
2.41
1.5
1.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
9
27
3.39
2.40
1.9
1.9
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
8
6.31
2.38
1.0
1.0
—
—
—
0
0
(4035726)
39
239
1.70
2.36
1.3
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
63
436
1.53
2.34
1.9
1.5
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
84
619
1.45
2.29
3.0
2.4
ng/l
1680.4
853.6
0.42
74
503
(3051611) Lipemic interference index of Serum or Plasma
8
23
3.53
2.28
3.8
3.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
6
13
4.67
2.28
1.0
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
23
121
1.96
2.26
2.0
1.6
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
14
60
2.38
2.24
1.1
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
14
60
2.38
2.24
1.1
1.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
30
173
1.79
2.24
1.8
2.9
e9/l
76.1
71.2
0.26
18
126
(3048929) Epstein Barr virus Ab [Presence] in Serum
24
129
1.91
2.22
1.3
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
11
42
2.66
2.20
1.4
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
30
3.04
2.16
1.8
1.9
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
15
68
2.25
2.13
1.3
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
107
834
1.39
2.13
1.7
1.6
mmol/l
1.4
1.4
0.15
92
719
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
12
49
2.49
2.12
2.3
1.9
—
—
—
0
0
(4306422)
12
49
2.49
2.12
1.1
1.2
—
—
—
0
0
(44790048)
8
25
3.24
2.10
2.5
1.6
—
—
—
0
0
(44806118)
8
25
3.24
2.10
2.5
1.6
—
—
—
0
0
(44790049)
8
25
3.24
2.10
2.5
1.6
—
—
—
0
0
(44790047)
8
25
3.24
2.10
2.5
1.6
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
9
31
2.95
2.08
1.9
1.9
—
—
—
0
0
(3019225) pH of Specimen
11
245
0.43
2.08
3.1
3.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
353
3315
1.52
2.07
4.4
4.3
mmol/l
2.8
2.9
0.72
333
3090
(3045788) Cell count panel - Pleural fluid
6
15
4.04
2.04
1.8
1.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
10
38
2.67
2.02
1.8
1.8
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
9
32
2.85
2.01
1.0
1.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
85
644
1.41
1.99
1.4
1.3
iu/ml
15.6
32.2
2.40
22
213
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
6
16
3.79
1.94
1.0
1.0
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
39
2.60
1.93
2.4
1.7
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
17
85
2.04
1.93
2.1
5.4
g/l
0.2
0.2
0.06
12
35
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
14
65
2.20
1.90
1.0
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
12
52
2.35
1.89
2.3
1.8
—
—
—
0
0
(3022145) Colonoscopy Study observation
50
348
1.50
1.83
1.3
1.3
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
5
12
4.20
1.83
1.6
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
9
35
2.61
1.81
1.9
1.3
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
8
29
2.79
1.80
1.0
1.0
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
39
258
1.57
1.79
4.1
4.1
ug/l
32.6
24.2
0.12
30
214
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
316
2933
1.36
1.76
5.7
4.7
mmol/mol
38.7
38.6
0.07
300
2756
(4268621)
9
36
2.53
1.75
2.2
2.2
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
13
61
2.17
1.73
1.2
1.2
u/ml
3.2
8.0
—
6
24
(3025130) Human papilloma virus identified in Specimen
13
61
2.17
1.73
1.7
1.7
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
336
3152
1.40
1.72
3.5
3.5
mmol/l
1.3
1.3
0.34
317
2950
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
12
55
2.22
1.69
2.1
2.0
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
7
25
2.83
1.65
1.4
1.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
5
14
3.60
1.62
1.6
1.4
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
7
156
0.44
1.58
1.1
1.4
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
7
26
2.72
1.58
1.1
1.1
nmol/l
1.3
1.4
—
7
21
(3036603) Volume of Urine
6
20
3.03
1.58
1.3
1.5
—
1872.6
—
0
5
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
82
642
1.35
1.57
1.9
1.6
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
13
64
2.07
1.56
2.5
2.4
—
—
—
0
0
(3002256) Pathology report gross observation
52
378
1.43
1.55
1.3
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
28
178
1.62
1.53
1.7
1.4
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
5
15
3.36
1.53
1.0
1.0
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
7
27
2.62
1.52
1.4
1.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
21
124
1.73
1.50
1.6
1.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
37
254
1.50
1.47
1.8
1.6
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
7
28
2.53
1.46
1.6
1.2
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
21
126
1.70
1.43
2.0
2.8
%
0.6
0.6
0.43
21
121
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
9
40
2.28
1.41
2.6
1.6
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
344
3268
1.36
1.38
4.1
3.9
mmol/l
4.8
4.8
0.14
329
3076
(3021788) Differential panel - Synovial fluid
9
41
2.22
1.38
1.4
1.9
—
—
—
0
0
(3011648) Oxygen content in Venous blood
6
23
2.63
1.37
1.8
3.3
%
9.4
11.4
—
6
23
(3047352) Trisomy 18 risk [Likelihood] in Fetus
20
120
1.70
1.37
1.5
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
20
120
1.70
1.37
1.5
1.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
343
3260
1.35
1.34
4.0
3.9
mmol/l
1.5
1.5
0.30
323
3053
(3021901) Oxygen saturation in Capillary blood
9
42
2.17
1.34
1.8
2.0
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
9
42
2.17
1.34
1.1
1.3
nmol/l
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
39
277
1.45
1.33
4.7
3.2
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
21
129
1.66
1.32
2.0
2.7
%
1.0
1.3
1.05
21
129
(3027944) Amphetamines [Presence] in Urine
28
186
1.54
1.30
1.7
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
28
186
1.54
1.30
1.7
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
28
186
1.54
1.30
1.7
1.4
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
23
146
1.61
1.29
1.3
1.4
miu/ml
262.6
265.4
—
9
76
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
5
18
2.80
1.29
2.0
1.3
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
6
25
2.42
1.25
1.3
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
15
85
1.79
1.24
2.5
2.6
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
10
49
2.07
1.23
1.0
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
19
2.65
1.22
3.2
1.3
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
19
2.65
1.22
3.0
1.3
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
5
19
2.65
1.22
2.2
1.9
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
57
441
1.34
1.20
1.9
1.7
%
1.4
1.4
0.31
49
397
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
27
182
1.52
1.19
2.0
2.4
ug/l
4.8
6.6
0.44
21
163
(3012441) Differential panel - Pleural fluid
5
20
2.52
1.15
1.4
1.5
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
5
20
2.52
1.15
1.0
1.7
u/field
3.0
1.0
—
5
14
(3000764) Benzodiazepines [Presence] in Urine
27
184
1.50
1.14
1.7
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
46
348
1.36
1.12
1.9
1.8
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
32
228
1.44
1.09
1.2
1.4
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
5
21
2.40
1.09
1.2
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
8
41
1.97
1.09
1.5
1.6
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
7
32
2.21
1.08
3.1
2.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
12
67
1.82
1.05
1.2
1.2
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
5
22
2.29
1.03
1.2
1.1
mmol/l
1.5
1.7
—
5
22
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
77
635
1.26
1.03
1.3
1.3
u/ml
7.2
11.5
0.40
29
262
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
37
276
1.38
1.00
1.6
1.7
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
9
49
1.86
0.99
2.7
3.4
u/ml
12.3
18.6
—
9
49
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
9
49
1.86
0.99
1.1
1.3
nmol/l
0.5
0.5
—
9
44
(1001926) Buprenorphine [Presence] in Urine by Screen method
22
149
1.50
0.97
1.8
1.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
9
50
1.82
0.97
1.1
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
12
70
1.74
0.93
2.3
1.9
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
10
56
1.81
0.88
1.0
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
22
154
1.45
0.85
1.5
1.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
50
402
1.28
0.83
2.1
1.8
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
11
65
1.71
0.83
1.4
1.2
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
10
58
1.74
0.80
1.1
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
6
34
1.78
0.76
1.5
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
6
34
1.78
0.76
1.2
1.4
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
28
0.00
0.76
0.0
3.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
33
254
1.33
0.76
3.2
2.2
ml/min/173m2
70.9
75.4
0.39
13
108
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
22
158
1.42
0.76
1.6
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
9
54
1.68
0.75
1.1
2.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
86
745
1.20
0.74
1.5
1.4
—
—
—
0
0
(4034850)
6
110
0.54
0.73
17.0
7.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
9
56
1.62
0.73
1.1
1.1
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
12
76
1.60
0.72
4.3
4.1
mg/l
1.5
1.3
0.54
12
68
(3009508) Creatinine [Moles/volume] in Urine
99
871
1.18
0.72
3.3
3.0
mmol/l
6.9
8.0
1.54
87
736
(3042111) Morphology [Interpretation] in Bone marrow Narrative
7
40
1.76
0.71
1.0
1.3
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
20
143
1.42
0.71
1.5
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
20
143
1.42
0.71
1.5
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
20
143
1.42
0.71
1.5
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
20
143
1.42
0.71
1.5
1.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
5
27
1.86
0.68
1.0
1.2
—
—
—
0
0
(3020891) Body temperature
14
94
1.51
0.67
3.0
5.3
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
5
28
1.80
0.66
1.0
1.1
u/l
38.6
60.8
—
5
18
(4281824)
5
28
1.80
0.66
1.2
1.1
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
10
62
1.63
0.65
1.4
1.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
5
29
1.73
0.64
2.6
2.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
19
139
1.39
0.61
2.6
3.6
mmol/l
2.4
1.6
0.43
14
105
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
140
1281
1.14
0.61
4.0
3.2
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
21
0.00
0.60
0.0
1.3
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
6
36
1.68
0.57
1.2
1.7
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
6
37
1.63
0.55
1.2
1.2
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
9
62
1.46
0.53
1.2
1.2
ug/l
2.2
2.9
—
9
56
(3045414) Leukocytes [Presence] in Urine
17
126
1.36
0.52
2.0
1.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
102
924
1.14
0.51
4.3
2.8
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
27
334
0.79
0.51
6.0
6.0
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
7
45
1.57
0.49
7.4
5.2
umol/l
438.9
360.5
—
7
39
(1761868) Lipid panel - Serum or Plasma
125
1352
0.89
0.48
2.4
2.4
—
—
—
0
0
(3009343) pH of Capillary blood
19
146
1.32
0.48
2.7
3.6
ph
7.4
7.4
—
5
19
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
52
597
0.85
0.47
4.4
4.2
ug/l
1.6
2.0
0.83
46
530
(4094501)
12
86
1.41
0.45
1.0
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
54
474
1.16
0.43
1.6
1.7
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
5
32
1.57
0.42
1.2
1.1
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
5
33
1.52
0.41
1.2
1.1
mg/l
364.8
292.4
—
5
28
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
17
0.00
0.40
0.0
1.2
—
6.7
—
0
17
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
17
0.00
0.40
0.0
1.6
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
24
197
1.23
0.38
2.5
2.1
u/l
20131.1
6620.3
—
6
75
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
42
481
0.86
0.38
3.5
3.8
%
20.5
20.3
0.03
12
211
(3044290) Cell count panel - Cerebral spinal fluid
9
68
1.33
0.38
1.0
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
68
615
1.13
0.36
2.0
2.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
6
41
1.47
0.36
1.0
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
80
735
1.11
0.33
3.7
3.2
mg/l
61.4
242.3
0.76
50
479
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
6
47
1.28
0.32
1.0
1.3
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
8
108
0.74
0.29
1.5
1.6
—
—
—
0
0
(3013512) EKG study
71
769
0.91
0.29
3.6
3.0
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
18
149
1.22
0.28
2.4
2.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
62
568
1.11
0.28
1.7
1.6
pmol/l
438.9
15145659.7
0.50
49
482
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
61
562
1.10
0.25
1.9
1.9
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
11
87
1.27
0.24
1.3
1.7
nmol/l
58.5
39.2
0.73
11
87
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
5
39
1.29
0.23
1.0
1.0
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
84
790
1.08
0.23
4.7
3.9
mg/mmol
9.1
8.5
0.06
51
502
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
11
88
1.26
0.22
1.1
1.2
mg/l
352.5
424.0
0.87
11
80
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
7
93
0.75
0.22
1.3
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
17
144
1.19
0.22
7.3
2.8
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
5
41
1.22
0.22
4.6
2.8
u/ml
3.4
105.5
—
5
36
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
5
41
1.22
0.22
1.0
1.1
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
10
0.00
0.21
0.0
6.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(4133840)
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
5
43
1.16
0.21
1.0
1.2
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
13
0.00
0.21
0.0
2.3
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
14
118
1.19
0.19
1.2
1.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
15
175
0.85
0.19
1.2
1.4
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
7
58
1.21
0.18
1.3
1.4
nmol/l
1.1
0.9
—
7
48
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
10
121
0.82
0.18
1.2
1.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
9
80
1.13
0.15
1.9
1.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
8
100
0.80
0.13
2.3
1.7
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
22
199
1.11
0.13
8.2
2.4
u/ml
58.4
44.1
0.15
22
191
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
5
44
1.14
0.10
1.0
1.0
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
5
46
1.09
0.09
1.0
1.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
19
174
1.10
0.09
1.1
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
14
155
0.90
0.09
1.4
1.9
—
—
—
0
0
(3022621) pH of Urine by Test strip
21
194
1.09
0.09
2.4
2.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
5
64
0.78
0.08
15.0
3.7
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
7
64
1.10
0.08
1.0
1.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
7
80
0.87
0.07
1.9
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
9
100
0.90
0.06
2.3
1.8
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
45
434
1.04
0.06
1.4
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
102
1000
1.03
0.06
1.7
1.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
31
296
1.05
0.06
1.3
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
24
227
1.06
0.06
2.3
3.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
86
876
0.98
0.04
3.9
3.4
estimate
0.0
0.0
0.50
37
310
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
40
410
0.97
0.03
1.7
1.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
10
106
0.94
0.01
3.0
3.9
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
72
714
1.01
0.00
3.5
3.3
kg/l
1.0
1.0
—
8
87
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
12
119
1.01
0.00
3.4
1.9
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
36
357
1.01
0.00
3.0
2.6
ug/l
0.5
0.7
1.17
23
219
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
27
265
1.02
0.00
1.5
1.5
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
5
51
0.98
0.00
1.0
1.1
—
17.8
—
0
10
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
6
65
0.92
0.00
1.7
1.3
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
5
0.00
0.00
0.0
1.2
—
0.9
—
0
5
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.1
—
16.7
—
0
7
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
8
80
1.00
0.00
1.0
1.2
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
5
0.00
0.00
0.0
6.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806420)
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
0
9
0.00
0.00
0.0
1.3
—
728.6
—
0
9
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806071)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: Z21_PERSONAL_HISTORY_ALLERGY_DRUGS_MEDICAM_BIOLO_SUBST – Personal history of allergy to drugs, medicaments and biological substances
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).